Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Nancy S. Lurker

Nancy S. Lurker is recorded as Chairman and Board Member at EyePoint, Inc. (EYPT). EyePoint, Inc. reported in an 8-K filed July 10, 2023 that Nancy S. Lurker was appointed Vice Chair of the Board, effective July 10, 2023. EyePoint, Inc. reported in an 8-K filed July 10, 2023 that Nancy S. Lurker was appointed Executive Vice Chair, effective July 10, 2023. EyePoint, Inc. reported in an 8-K filed June 21, 2023 that Nancy S. Lurker was appointed Director, effective June 20, 2023.

“Ms. Lurker will continue to serve as a member of the Board and was appointed to serve as the Vice Chair of the Board as of the Lurker Transition Date.”
EyePoint, Inc. Form 8-K, filed July 10, 2023 · Read the filing
“Effective as of July 10, 2023 (the "Lurker Transition Date"), Nancy S. Lurker transitioned from her role as Chief Executive Officer of EyePoint Pharmaceuticals, Inc. (the "Company") to Executive Vice Chair of the Company.”
EyePoint, Inc. Form 8-K, filed July 10, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at EyePoint, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.